Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia
- 1 April 2000
- Vol. 55 (4) , 533-539
- https://doi.org/10.1016/s0090-4295(99)00593-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Watchful waiting or drug therapy for benign prostatic hyperplasia?The Lancet, 1997
- Urodynamic Effects of Doxazosin in Men with Lower Urinary Tract Symptoms and Benign Prostatic ObstructionEuropean Urology, 1997
- Serenoa repens (Permixon®)Drugs & Aging, 1996
- Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trialsUrology, 1996
- Phytotherapy for the prostateBritish Journal of Urology, 1996
- Phytotherapy in treatment of benign prostatic hyperplasia: a critical reviewUrology, 1996
- Vesicourethral healing following radical prostatectomy: Is it related to surgical approach?Urology, 1994
- Novel aromatase and 5α-reductase inhibitorsThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- Endocrine properties of the testosterone 5α-reductase inhibitor turosteride (FCE 26073)The Journal of Steroid Biochemistry and Molecular Biology, 1994
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991